The vaccine maker’s shots involve the successful mRNA technology used in the Covid vaccines. Health Secretary Robert F.
The decision, which shocked company officials, comes as the FDA says it will take a stricter approach to federal vaccine ...
FDA refuses Moderna's mRNA flu vaccine application, citing inadequate study design, as the company disputes decision, saying it contradicts prior FDA guidance.
By Rashika Singh Feb 11 (Reuters) - Shares of Moderna fell 10.3% premarket on Wednesday after the U.S. Food and Drug ...
The Food and Drug Administration is refusing to consider Moderna's application for a new flu vaccine made with mRNA technology, the company said.
Refusal to review the submission is inconsistent with feedback at pre-Phase 3 and pre-submission consultations; Moderna ...
Moderna said on Tuesday the U.S. Food and Drug Administration will not review its approval application for its influenza ...
Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent ...
Moderna noted the FDA did not identify any specific safety concerns with the vaccine and that the rejection was inconsistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results